| T cells in multiple myeloma display features of exhaustion and senescence at the tumor site C Zelle-Rieser, S Thangavadivel, R Biedermann, A Brunner, P Stoitzner, ... Journal of hematology & oncology 9, 1-12, 2016 | 250 | 2016 |
| Fibrocyte migration, differentiation and apoptosis during the corneal wound healing response to injury L Lassance, GK Marino, CS Medeiros, S Thangavadivel, SE Wilson Experimental eye research 170, 177-187, 2018 | 76 | 2018 |
| Epithelial basement membrane injury and regeneration modulates corneal fibrosis after pseudomonas corneal ulcers in rabbits GK Marino, MR Santhiago, A Santhanam, L Lassance, S Thangavadivel, ... Experimental eye research 161, 101-105, 2017 | 59 | 2017 |
| Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations F Lucas, K Larkin, CT Gregory, S Orwick, TJ Doong, A Lozanski, ... Blood, The Journal of the American Society of Hematology 135 (24), 2192-2195, 2020 | 48 | 2020 |
| Basement membranes in the cornea and other organs that commonly develop fibrosis P Saikia, CS Medeiros, S Thangavadivel, SE Wilson Cell and tissue research 374, 439-453, 2018 | 42 | 2018 |
| Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis S Kshirsagar, M Riedl, H Billing, B Toenshoff, S Thangavadivel, C Steuber, ... The Journal of Immunology 193 (10), 4895-4903, 2014 | 33 | 2014 |
| IL-1 and TGF-β Modulation of Epithelial Basement Membrane Components Perlecan and Nidogen Production by Corneal Stromal Cells. P Saikia, S Thangavadivel, CS Medeiros, L Lassance, RC de Oliveira, ... Investigative ophthalmology & visual science 59 (13), 5589, 2018 | 29 | 2018 |
| The impact of photorefractive keratectomy and mitomycin C on corneal nerves and their regeneration CS Medeiros, GK Marino, L Lassance, S Thangavadivel, MR Santhiago, ... Journal of Refractive Surgery 34 (12), 790-798, 2018 | 27 | 2018 |
| Adipocyte-derived players in hematologic tumors: useful novel targets? K Joehrer, C Ploner, S Thangavadivel, P Wuggenig, R Greil Expert Opinion on Biological Therapy 15 (1), 61-77, 2015 | 18 | 2015 |
| Gly101Val BCL2 mutation: one step closer to understanding venetoclax resistance in CLL S Thangavadivel, JC Byrd Cancer discovery 9 (3), 320-322, 2019 | 11 | 2019 |
| CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma S Thangavadivel, C Zelle-Rieser, A Olivier, B Postert, G Untergasser, ... Oncotarget 7 (48), 78605, 2016 | 8 | 2016 |
| Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a … W Willenbacher, S Thangavadivel, R Greil, E Willenbacher, R Weger, ... Leukemia & Lymphoma 57 (10), 2330-2341, 2016 | 5 | 2016 |
| Early intervention with lenalidomide in patients with high-risk chronic lymphocytic leukemia S Thangavadivel, Q Zhao, N Epperla, L Rike, X Mo, M Badawi, DM Bystry, ... Clinical Cancer Research 26 (23), 6187-6195, 2020 | 4 | 2020 |
| A phase 2 trial of early intervention with ibrutinib in patients with asymptomatic, high-risk CLL FT Awan, S Thangavadivel, D Weiss, L Wei, JA Woyach, KA Rogers, ... Blood 130, 1748, 2017 | 3 | 2017 |
| Genomics of resistance to targeted therapies S Thangavadivel, JA Woyach Hematology/Oncology Clinics 35 (4), 715-724, 2021 | 2 | 2021 |
| Final Results of a Phase 2 Trial of Early Intervention Ibrutinib with Vaccinations in Patients with Asymptomatic, High-Risk CLL J Woyach, S Thangavadivel, D Weiss, L Wei, E McLaughlin, K Rogers, ... Blood 134, 1759, 2019 | 1 | 2019 |
| T Cell Dysfunction and Exhaustion in Patients with CLL: The Impact of Long Term Ibrutinib Treatment S Thangavadivel, C Mao, M Long, S Misra, S Benrashid, B Gordon, A He, ... Blood 142, 4631, 2023 | | 2023 |
| Targeting Covalent and Non-Covalent Btki-Resistant CLL Using the Dual Irreversible/Reversible 4 th Generation BTK Inhibitor LP-168 B Gordon, E Muhowski, J Ravikrishnan, S Benrashid, A Mitchell, A He, ... Blood 142, 416, 2023 | | 2023 |
| Extended Follow up of a Phase 2 Study of Early Intervention with Lenalidomide in Patients with High-Risk Chronic Lymphocytic Leukemia KA Rogers, Q Zhao, SA Bhat, JC Byrd, C Grantier, MR Grever, C Hoffman, ... Blood 142, 3272, 2023 | | 2023 |
| Single-Cell RNA-Seq Analysis Reveals Distinct Tumor and Immunosuppressive T Cell Phenotypes in CLL Patients Treated with Ibrutinib S Thangavadivel, S Misra, S Benrashid, B Gordon, A He, TH Lai, ... Blood 142, 3262, 2023 | | 2023 |
